# Phase 2/3 Carcinoma, Non-Small-Cell Lung trials: 22 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials in phase 2/3 for Carcinoma, Non-Small-Cell Lung that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2/3 Carcinoma, Non-Small-Cell Lung trials: 22 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2-3/carcinoma-non-small-cell-lung

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 22
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 22, 2026 | NCT07888075 | Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or... | AVEO Pharmaceuticals, Inc. | Phase 2/3 | Not yet recruiting | Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome, Metastatic Colorectal Cancer (CRC), Metastatic Non-small Cell... | 950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888075) |
| October 8, 2026 | NCT07865910 | A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With... | Shanghai Henlius Biotech | Phase 2/3 | Not yet recruiting | NSCLC (Advanced Non-small Cell Lung Cancer) | 1,438 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865910) |
| July 22, 2026 | NCT07718737 | Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype... | Multitude Therapeutics Inc. | Phase 2/3 | Recruiting | NSCLC (Advanced Non-small Cell Lung Cancer) | 512 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07718737) |
| June 23, 2026 | NCT07662811 | SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung Cancer | Shanghai Chest Hospital | Phase 2/3 | Not yet recruiting | Non-Small Cell Lung Cancer | 396 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662811) |
| June 23, 2026 | NCT07662395 | SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer | Sinocelltech Ltd. | Phase 2/3 | Recruiting | Double Blind | 410 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662395) |
| June 11, 2026 | NCT07642024 | A Study of BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients With EGFR-mutated Resectable Non-small Cell Lung... | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 2/3 | Recruiting | Non-small Cell Lung Cancer | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07642024) |
| February 27, 2026 | NCT07440290 | DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF... | Cancer Research UK | Phase 2/3 | Recruiting | Haematological Malignancy, Malignant Neoplasm, Lymphoproliferative Disorders, Neoplasms by Histologic Type, Neoplasms... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07440290) |
| January 26, 2026 | NCT07365319 | A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung... | Eikon Therapeutics | Phase 2/3 | Recruiting | Non Small Cell Lung Cancer (Squamous or Non Squamous), Stage 4 NSCLC | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07365319) |
| October 8, 2025 | NCT07213375 | High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy | Copenhagen University Hospital, Rigshospitalet | Phase 2/3 | Recruiting | Analgetic, Lung Cancer (NSCLC), Video Assisted Thoracic Surgery (VATS), Glucocorticoid | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07213375) |
| September 4, 2025 | NCT07155187 | A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination... | AbbVie | Phase 2/3 | Recruiting | Non-Small Cell Lung Cancer, c-MET | 490 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07155187) |
| September 2, 2025 | NCT07149649 | Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) | Swiss Cancer Institute | Phase 2/3 | Recruiting | Metastatic NSCLC - Non-Small Cell Lung Cancer | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07149649) |
| August 20, 2025 | NCT07131319 | SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC | Second Affiliated Hospital of Nanchang University | Phase 2/3 | Recruiting | Non-Small Cell Lung Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07131319) |
| August 3, 2025 | NCT07100080 | Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small... | Bristol-Myers Squibb | Phase 2/3 | Recruiting | Non-Small Cell Lung Cancer | 661 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07100080) |
| June 24, 2025 | NCT07034326 | Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer | Sponsor not shown (see the record) | Phase 2/3 | Recruiting | Non-Small Cell Lung Cancer, Electroacupuncture, Immune Checkpoint Inhibitors | 405 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07034326) |
| December 2, 2024 | NCT06712316 | Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA... | BioNTech SE | Phase 2/3 | Recruiting | Non-small Cell Lung Cancer | 1,580 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06712316) |
| September 27, 2024 | NCT06616584 | Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment... | SWOG Cancer Research Network | Phase 2/3 | Recruiting | Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 378 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06616584) |
| May 16, 2024 | NCT06417008 | A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer | Hansoh BioMedical R&D Company | Phase 2/3 | Recruiting | Non-Squamous Non-Small Cell Lung Cancer | 1,080 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06417008) |
| March 14, 2023 | NCT05768178 | DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. | Cancer Research UK | Phase 2/3 | Recruiting | Haematological Malignancy, Melanoma, Thyroid Cancer, Papillary, Ovarian Neoplasms, Colorectal Neoplasms, Laryngeal... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05768178) |
| February 24, 2022 | NCT05255302 | De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy... | Intergroupe Francophone de Cancerologie Thoracique | Phase 2/3 | Recruiting | Metastatic NSCLC | 1,360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05255302) |
| November 3, 2020 | NCT04613596 | Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients... | Mirati Therapeutics Inc. | Phase 2/3 | Recruiting | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 626 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04613596) |
| March 26, 2020 | NCT04322617 | Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer | Hunan Province Tumor Hospital | Phase 2/3 | Recruiting | Non-small Cell Lung Cancer | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04322617) |
| May 20, 2015 | NCT02448992 | Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer | Chang Gung Memorial Hospital | Phase 2/3 | Recruiting | Non-Small-Cell Lung Cancer (NSCLC), Brain Metastasis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02448992) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Cancer Research UK | 2 |
| Swiss Cancer Institute | 1 |
| [Hansoh BioMedical R&D Company](https://specstream.ai/data/clinical-trials/company/hansoh-biomedical-r-and-d-company) | 1 |
| Shanghai Chest Hospital | 1 |
| [Sichuan Baili Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/sichuan-baili-pharmaceutical-co-ltd) | 1 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 1 |
| Intergroupe Francophone de Cancerologie Thoracique | 1 |
| [Mirati Therapeutics Inc.](https://specstream.ai/data/clinical-trials/company/mirati-therapeutics-inc) | 1 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 1 |
| Hunan Province Tumor Hospital | 1 |
| Eikon Therapeutics | 1 |
| [Shanghai Henlius Biotech](https://specstream.ai/data/clinical-trials/company/shanghai-henlius-biotech) | 1 |
| SWOG Cancer Research Network | 1 |
| [BioNTech SE](https://specstream.ai/data/clinical-trials/company/biontech-se) | 1 |
| Chang Gung Memorial Hospital | 1 |
| Multitude Therapeutics Inc. | 1 |
| Copenhagen University Hospital, Rigshospitalet | 1 |
| [Sinocelltech Ltd.](https://specstream.ai/data/clinical-trials/company/sinocelltech-ltd) | 1 |
| [AVEO Pharmaceuticals, Inc.](https://specstream.ai/data/clinical-trials/company/aveo-pharmaceuticals-inc) | 1 |
| Second Affiliated Hospital of Nanchang University | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 11 |
| United States | 7 |
| United Kingdom | 6 |
| Belgium | 5 |
| France | 5 |
| Germany | 5 |
| Italy | 5 |
| Poland | 5 |
| South Korea | 5 |
| Spain | 5 |
| Australia | 5 |
| Switzerland | 4 |
| Argentina | 4 |
| Japan | 4 |
| Romania | 4 |
| Taiwan | 4 |
| Canada | 3 |
| Chile | 3 |
| Greece | 3 |
| Netherlands | 3 |
| Thailand | 3 |
| Austria | 3 |
| Brazil | 3 |
| Turkey (Türkiye) | 3 |
| Colombia | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Valet services in the United States](https://specstream.ai/data/businesses/valet-services/united-states)
- [Infectious disease clinics in the United States](https://specstream.ai/data/businesses/infectious-disease-clinics/united-states)
- [AV equipment rental companies in the United States](https://specstream.ai/data/businesses/av-equipment-rental-companies/united-states)
- [Mills in the United States](https://specstream.ai/data/businesses/mills/united-states)
- [Cambodian restaurants in the United States](https://specstream.ai/data/businesses/cambodian-restaurants/united-states)
- [Preschools in the United States](https://specstream.ai/data/businesses/preschools/united-states)
